Cargando…
DEPDC1B promotes development of cholangiocarcinoma through enhancing the stability of CDK1 and regulating malignant phenotypes
Cholangiocarcinoma (CCA) is the second most common primary tumor of the hepatobiliary system. At present, the therapeutic efficiency of cholangiocarcinoma is fairly low and the prognosis is poor. The root cause is that the molecular mechanism of the occurrence and development of CCA is largely uncle...
Autores principales: | Zhang, Zhenhai, Wang, Xinxing, Nie, Peihua, Qin, Yejun, Shi, Junping, Xu, Shifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769124/ https://www.ncbi.nlm.nih.gov/pubmed/36568241 http://dx.doi.org/10.3389/fonc.2022.842205 |
Ejemplares similares
-
High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer
por: Zhao, Huishan, et al.
Publicado: (2019) -
Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1
por: Dang, Xiao-Wei, et al.
Publicado: (2021) -
FOXM1 is regulated by DEPDC1 to facilitate development and metastasis of oral squamous cell carcinoma
por: Qiu, Jing, et al.
Publicado: (2022) -
The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma
por: Suppramote, Orawan, et al.
Publicado: (2022) -
Knockdown of DEPDC1B inhibits the development of glioblastoma
por: Chen, Xu, et al.
Publicado: (2020)